Techseriesinsight
  • Home
  • News
    • Advertising & Promotion
      • Content Marketing
      • Marketing Automation
      • Press Release
      • Sales & Marketing
      • Social Media
    • Analytics
      • Cloud
      • Data Center
      • Data Management Platform
      • Storage
    • Artificial Intelligence
      • RoboticsExplore the latest in robotics tech news. Stay updated on innovations, trends, and developments in this exciting field.
    • Biotechnology
    • Business Broadcast
    • Customer Experience
    • E-Commerce
    • Healthcare
    • Joint Ventures
    • Networking
      • Blockchain TechnologyBlockchain Technology
      • Internet of Things (IoT)Internet of Things (IoT)
    • Security
  • Insights
  • Resource Hub
    • AI / ML
    • Cloud Technology
    • Customer Engagement
    • Information Technology
    • Security
    • Tech & Work
Techseriesinsight
Techseriesinsight
  • Home
  • News
    • Advertising & Promotion
      • Content Marketing
      • Marketing Automation
      • Press Release
      • Sales & Marketing
      • Social Media
    • Analytics
      • Cloud
      • Data Center
      • Data Management Platform
      • Storage
    • Artificial Intelligence
      • RoboticsExplore the latest in robotics tech news. Stay updated on innovations, trends, and developments in this exciting field.
    • Biotechnology
    • Business Broadcast
    • Customer Experience
    • E-Commerce
    • Healthcare
    • Joint Ventures
    • Networking
      • Blockchain TechnologyBlockchain Technology
      • Internet of Things (IoT)Internet of Things (IoT)
    • Security
  • Insights
  • Resource Hub
    • AI / ML
    • Cloud Technology
    • Customer Engagement
    • Information Technology
    • Security
    • Tech & Work

#company

Techseriesinsight > Blog > #company
  • May 9, 2025
  • PRNewswire
  • Biotechnology

IASO Bio Receives Orphan Drug Designation from the Saudi Food and Drug Authority for Equecabtagene Autoleucel

IASO Biotherapeutics (“IASO Bio”), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced that its self-developed BCMA-targeted CAR-T cell...
Continue Reading
  • May 9, 2025
  • PRNewswire
  • Biotechnology

Minghui Pharmaceutical Announces Strategic Partnership and Licensing Agreement with Qilu Pharmaceutical to Develop B7-H3 ADC in Greater China

 Minghui Pharmaceutical (“Minghui”), a late-stage clinical biopharmaceutical company, today announced an exclusive licensing and collaboration agreement with Qilu Pharmaceutical (“Qilu”) for the development, manufacturing, and commercialization of its B7-H3...
Continue Reading
  • May 8, 2025
  • PRNewswire
  • Healthcare

Diatonic Healthcare Announces Majority Growth Investment in Quantix

Diatonic Healthcare (“Diatonic”), a middle market private equity firm focused on healthcare technology and tech-enabled services, today announced a growth investment in Quantix Consulting (“Quantix”), a healthcare and regulated industry...
Continue Reading
  • May 8, 2025
  • PRNewswire
  • Biotechnology

TransCode Therapeutics Successfully Completes Initial Dosing of Patients in Cohort 4 of Phase 1a Clinical Trial; No Dose Limiting Toxicities Reported

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that the third patient in Cohort 4 of its Phase...
Continue Reading
  • May 7, 2025
  • PRNewswire
  • Healthcare

Novavax to Participate in BofA Securities 2025 Health Care Conference

Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the BofA Securities 2025 Health Care Conference. A webcast of the fireside chat will be available on the Events...
Continue Reading
  • May 7, 2025
  • PRNewswire
  • Cloud

Akamai and FPT Partner to Help Customers Build and Support Cloud-Native Applications

Akamai Technologies (NASDAQ: AKAM), the cybersecurity and cloud computing company that powers and protects business online, today announced a new partnership with global IT services leader FPT. As a newly appointed global...
Continue Reading
  • May 7, 2025
  • PRNewswire
  • Blockchain Technology

Cango Inc. Maintains Strong Mining Efficiency and Expands Bitcoin Holdings Amidst April Production Shift

Cango Inc. (NYSE: CANG), a leading bitcoin mining company, recently released its April 2025 production update for its crypto mining operations. In April 2025, Cango mined a total of 470.0 Bitcoins, an 11.3% decrease compared to 530.1...
Continue Reading
  • May 6, 2025
  • PRNewswire
  • Biotechnology

Factor Bioscience to Present Non-Viral Gene Editing and Cell Engineering Innovations at the ASGCT Annual Meeting

Factor Bioscience Inc., a Cambridge-based biotechnology company focused on using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced its participation in the American Society of...
Continue Reading
  • May 6, 2025
  • PRNewswire
  • Biotechnology

Galmed Announces First Time Results in Oncology Studies: Aramchol Significantly Enhances Bayer’s Regorafenib Effect in GI Cancer Models

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) (“Galmed” or the “Company”), a clinical-stage biopharmaceutical company for cardiometabolic diseases and GI oncological therapeutics, announced today that the first set of oncology studies has...
Continue Reading
  • May 6, 2025
  • PRNewswire
  • Artificial Intelligence

Alphabiome Launches Groundbreaking AI Technology that Deciphers the Genetic Code of the Microbiome

Alphabiome, the first company to unlock the microbiome’s genetic code with advanced AI, today announces $8M seed funding from AIX Ventures alongside other investors. Despite its vast biological significance, the current...
Continue Reading

Posts navigation

Previous 1 … 7 8 9 … 11 Next

Search

Newsletter

Subscribe Our Free Newsletter

Loading

Get in Touch

  • 750 Followers
  • 950 Likes
  • 1250 Fans
  • 1050 Followers

Recent Posts

Blog_image
Consent-Driven Personalization and Transparent Data Practices January 23, 2026
HUMAIN and Infra
HUMAIN and Infra Announce AI and… January 23, 2026
Robo.ai Partners
Robo.ai Partners with The Ghazi Group… January 23, 2026
ImmunityBio Reports Median Overall Survival
ImmunityBio Reports Median Overall Survival Not… January 23, 2026
Equifax Introduces Enhanced
Equifax Introduces Enhanced Synthetic Identity Fraud… January 23, 2026

Hot Categories

Techseriesinsight

Techseriesinsight is a global digital platform that publishes content related to technology and business insights from industry experts. Get the latest news, discussions & strategic expertise with thoughts and assessments on business challenges.

Follow us

Quick links

  • Contact Us
  • Privacy Policy
  • Unsubscribe

Subscribe Our Free Newsletter

Loading

Techseriesinsight, 2024 © All Rights Reserved